Paul Riser Jr.

Paul Riser Jr. serves as managing director of technology-based entrepreneurship at TechTown Detroit, guiding the design, execution, and ongoing management of the nonprofit’s technology programming for early and seed stage companies. Riser is also the president and CEO of the Riser Group, a Northville, MI-based IT and business development consulting firm.

Recent posts

Detroit Trends in 2018? More Traction, Diversity, and Collaboration
Editor’s note: This is part of a series of posts sharing thoughts from industry and technology leaders about 2018 trends.
A few trends come to mind that continue to... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Xconomy Insight · Special Report
Biotech Startups: How to Succeed in a COVID-19 World
Industry experts explain what it takes to launch a new biotech company

Sponsored · Whitepaper
Biotech & Early Engagement Considerations: What Companies Must Consider When Developing an Asset
Evaluating an asset for development, including the vision, development and continuum capabilities, and global versus local development
PRA Health Sciences

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4

FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats

Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting

Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward

Generate Bio Aims to Reveal Nature’s Protein Secrets, Create New Drugs

Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs

Xcelerating Life Sciences New York

Paul Riser Jr.

Recent posts

Detroit Trends in 2018? More Traction, Diversity, and Collaboration

Underwriters and Partners

Biotech Startups: How to Succeed in a COVID-19 World

Biotech & Early Engagement Considerations: What Companies Must Consider When Developing an Asset

Potency Assay Development for Cell and Gene Therapy Products

Xconomy on Demand

We offer a number of ways to subscribe for free!